Skip to main content

Table 3 Monocyte count and RDW in subgroup of patients based on the need of LTOT

From: Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

 

LTOT

NO LTOT

P value

Median Monocyte count (derivation cohort), (95% CI)

0.70 (0.64–0.80)

0.56 (0.53–0.60)

< 0.001

Median Monocyte count (validation cohort), (95% CI)

0.60 (0.54–0.60)

0.50 (0.44–0.52)

0.004

Median RDW (derivation cohort), (95% CI)

15.1 (14.2–15.4)

13.9 (13.7–14.1)

0.002

Median RDW (validation cohort), (95% CI)

13.8 (13.6–14.3)

13.5 (13.2–13.8)

0.003

  1. CI confidence interval, LTOT long term oxygen therapy, RDW red cell distribution width